Company Filing History:
Years Active: 1998-2008
Title: Christine L Pampeno: Innovator in Viral Vector Technology
Introduction
Christine L Pampeno is a distinguished inventor based in New York, NY (US). She has made significant contributions to the field of viral vector technology, holding a total of four patents. Her work focuses on the development of innovative methods for the production and application of viral vectors.
Latest Patents
One of her latest patents is titled "Packaging cell lines for the continuous production of alphavirus vectors." This invention pertains to packaging cell lines that are particularly useful for the continuous production of Sindbis viral vectors at high efficiency. The packaging cell line comprises an insect cell that contains DNA encoding alphavirus structural proteins, replicase, and a replicon.
Another notable patent is "Viral vector complexes having adapters of predefined valence." This invention improves the methods of inserting and expressing foreign genes into eukaryotic cells. It particularly concerns methods and compositions that utilize viral vectors to insert and express foreign genes into cells with specific differentiation antigens. The invention also teaches a method for determining which differentiation antigens can be used, encompassing complexes of viral particles and adapters that facilitate the binding and internalization of vector particles, ensuring that a gene of interest is expressed.
Career Highlights
Christine L Pampeno is affiliated with New York University, where she continues her research and development in viral vector technology. Her innovative work has positioned her as a key figure in her field, contributing to advancements that have the potential to impact various applications in medicine and biotechnology.
Collaborations
Some of her notable coworkers include Daniel Meruelo and Koichi Ono, who have collaborated with her on various projects related to viral vectors and their applications.
Conclusion
Christine L Pampeno is a pioneering inventor whose work in viral vector technology has led to significant advancements in the field. Her contributions are shaping the future of gene therapy and biotechnology.